SCHEMBL7181445

SCHEMBL7181445

CCCCOC(C)COCCO

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.56
TDP1 Q9NUW8 1/20 0.50
HTT P42858 2/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
THRB P10828 1/20 0.45
MAPT P10636 1/20 0.45
USP2 O75604 2/20 0.40
ALDH1A1 P00352 2/20 0.39
HSD17B10 Q99714 1/20 0.39
LPAR1 Q92633 4/20 0.37
LPAR3 Q9UBY5 4/20 0.37
LPAR2 Q9HBW0 1/20 0.37
SPHK1 Q9NYA1 1/20 0.36
MAPK1 P28482 2/20 0.35
LMNA P02545 1/20 0.35
CYP3A4 P08684 1/20 0.35
CASP1 P29466 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
SLCO1B3 Q9NPD5 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4806772 0.96 TSHR (0.57) TSHRTDP1HTTMEN1KMT2A
SCHEMBL10484508 0.94 HTT (0.53) TSHRTDP1HTTMEN1KMT2A
SCHEMBL28161776 0.92 HTT (0.57) TSHRTDP1HTTMEN1KMT2A
Ethylene Glycol SCHEMBL6756784 0.92 TDP1 (0.50) TSHRTDP1HTTMEN1KMT2A
SCHEMBL8617152 0.92 TSHR (0.56) TSHRTDP1HTTMEN1KMT2A
SCHEMBL11457821 0.91 TSHR (0.61) TSHRTDP1HTTMEN1KMT2A
SCHEMBL11470088 0.91 TSHR (0.61) TSHRTDP1HTTMEN1KMT2A
SCHEMBL10608964 0.90 TDP1 (0.48) TSHRTDP1HTTMEN1KMT2A
SCHEMBL3590634 0.89 MEN1 (0.63) TSHRTDP1HTTMEN1KMT2A
SCHEMBL14503244 0.88 TSHR (0.57) TSHRTDP1HTTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9909053-B2 Polymer compositions CHEVRON U.S.A. INC. (US) 2018-03-06 US claimed
US-9902894-B2 Polymer compositions CHEVRON U.S.A. INC. (US) 2018-02-27 US claimed
US-9902895-B2 Polymer compositions CHEVRON U.S.A. INC. (US) 2018-02-27 US claimed
US-9896617-B2 Polymer compositions CHEVRON U.S.A. INC. (US) 2018-02-20 US claimed
EP-3212732-A1 POLYMER COMPOSITIONS Chevron U.S.A., Inc. (US) 2017-09-06 EP claimed
WO-2016069937-A1 POLYMER COMPOSITIONS CHEVRON U.S.A. INC. (US) 2016-05-06 WO claimed
US-20160122622-A1 POLYMER COMPOSITIONS CHEVRON U.S.A. INC. 2016-05-05 US claimed
US-20160122623-A1 POLYMER COMPOSITIONS CHEVRON U.S.A. INC. 2016-05-05 US claimed
US-20160122624-A1 POLYMER COMPOSITIONS CHEVRON U.S.A. INC. 2016-05-05 US claimed
US-20160122626-A1 POLYMER COMPOSITIONS CHEVRON U.S.A. INC. 2016-05-05 US claimed
EP-0057595-B1 GLASS CONTAINER COATING COMPOSITIONS CELANESE CORPORATION (US) 1985-01-02 EP claimed
US-12584062-B2 Method for stimulating injection wells using reducing agents JGS RESOURCES, LLC (US) 2026-03-24 US disclosed
US-12312534-B2 Treating fluid comprising hydrocarbons, water, and polymer CHEVRON U.S.A. INC. (US) 2025-05-27 US disclosed
US-12215276-B2 Ph control in fluid treatment CHEVRON U.S.A. INC. (US) 2025-02-04 US disclosed
US-20250011642-A1 METHOD FOR STIMULATING INJECTION WELLS USING REDUCING AGENTS JGS RESOURCES, LLC 2025-01-09 US disclosed
EP-0902023-A2 Process for preparing condensation product of hydroxy-substituted aromatic compounds and glyoxylic reactants The Lubrizol Corporation (US) 1999-03-17 EP disclosed
EP-0832874-A1 Process for preparing bis-substituted phenolic amides in the presence of an alcohol as solvent The Lubrizol Corporation (US) 1998-04-01 EP disclosed
US-5629448-A POLYETHER SOLVENT THE LUBRIZOL CORPORATION (US) 1997-05-13 US disclosed
EP-0084966-B1 AQUEOUS COMPOSITIONS CONTAINING OVERBASED MATERIALS The Lubrizol Corporation (US) 1989-11-08 EP disclosed
US-4468339-A AND SOLUBILIZER WHICH IS REACTION OF CARBOXYLIC ACID ACYLATING AGENT WITH HYDROCARBON SUBSTITMENT AND HYDROXYAMINE THE LUBRIZOL CORPORATION (US) 1984-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12584062-B2 Method for stimulating injection wells using reducing agents JAK2, SLC6A12, JAK3 TSHR 1262/4885TDP1 4758/4885HTT 662/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.